CVL-1001

N/A

Report date: 2025/10/20 14:18:09
NME

Base Information

Drug NameCVL-1001
Drug Alias NameCVL-1001
ClassificationSmall molecules
Mechanisms of ActionEmopamil-binding protein inhibitors
TargetsEmopamil-binding protein
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConvelo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesConvelo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A